Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT06534983
Title A Study to Evaluate the Efficacy and Safety of Autogene Cevumeran With Nivolumab Versus Nivolumab Alone in Participants With High-Risk Muscle-Invasive Urothelial Carcinoma (MIUC) (IMCODE004)
Acronym IMCODE004
Recruitment Recruiting
Gender both
Phase Phase II
Variant Requirements No
Sponsors Hoffmann-La Roche
Indications
Therapies
Age Groups: adult | senior
Covered Countries USA | ITA | DEU | CAN | AUS

Facility Status City State Zip Country Details
Memorial Sloan Kettering Cancer Center RECRUITING New York New York 10065 United States Details
Lyell McEwin Hospital; Clinical Trials Unit RECRUITING Elizabeth Vale South Australia 5112 Australia Details
Sunshine Hospital RECRUITING St Albans Victoria 3021 Australia Details
Jewish General Hospital RECRUITING Montreal Quebec H3T 1E2 Canada Details
Uniklinikum Heidelberg RECRUITING Heidelberg 69120 Germany Details
IFO - Istituto Regina Elena; Oncologia Medica RECRUITING Roma Lazio 00144 Italy Details
A.O.U di Verona Policlinico G.B. Rossi; Centro Ricerche Cliniche RECRUITING Verona Veneto 37134 Italy Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field